ArticleFrontiers in immunology2022

CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate.

Luana Moraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.